The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Sargsian V.D.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Kamyshova T.V.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Safarian A.S.
National Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russia, 101990
Akhmedzhanov N.M.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Nebieridze D.V.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Poddubskaia E.A.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava Rossii
Statins in real clinical practice: current guidelines, possibilities of new schemes for their use
Journal: Russian Journal of Preventive Medicine. 2019;22(3): 86‑91
Views: 5024
Downloaded: 175
To cite this article:
Sargsian VD, Kamyshova TV, Safarian AS, Akhmedzhanov NM, Nebieridze DV, Poddubskaia EA. Statins in real clinical practice: current guidelines, possibilities of new schemes for their use. Russian Journal of Preventive Medicine.
2019;22(3):86‑91. (In Russ.)
https://doi.org/10.17116/profmed20192203186
Cardiovascular diseases (CVD) are the main cause of premature death and early disability in most economically developed countries of the world and in the Russian Federation. CVD is associated just with atherosclerosis in a larger number of patients. Statins occupy one of the key places in the international clinical guidelines for the treatment and prevention of atherosclerotic CVD. However, despite the available information about the need to take statins and to achieve the target levels of total cholesterol and low-density lipoprotein cholesterol, there are practical problems in the correction of hypercholesterolemia in practical health care. The recommended target levels of cholesterol are rarely achieved and long-term adherence to prescribed statins is low. This article discusses the main differences between European (ESC/EAS) and American (ACC/AHA) guidelines for the treatment of dyslipidemia and for the decrease of blood cholesterol in order to reduce cardiovascular risk in adults, as well as the possibility of using them in Russian health care.
Authors:
Sargsian V.D.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Kamyshova T.V.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Safarian A.S.
National Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russia, 101990
Akhmedzhanov N.M.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Nebieridze D.V.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava RF, Moskva, Rossiia, 101990
Poddubskaia E.A.
FGBU "Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny" Minzdrava Rossii
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.